A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity

PHASE3CompletedINTERVENTIONAL

Enrollment

197

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions

SpasticityStroke

Interventions

DRUG

Botulinum toxin type A

Maximum dose 360 U

Trial Locations (1)

SMG-SNU Boramae Medical Center, 41, Borame-Gill, Dong Gjak-Gu, Seoul